Figure 3.

Kaplan‐Meier curves for distant metastasis‐free survival (DMFS) and overall survival (OS) in nasopharyngeal carcinoma patients. A, DMFS of patients with low or high levels of pretreatment Epstein‐Barr virus (EBV) DNA. B, DMFS of patients with low or high levels of pretreatment BamHI A rightward transcripts encoded microRNA (miR‐BART)7‐3p. C, DMFS of patients with low or high levels of pretreatment miR‐BART13‐3p. D, DMFS of 4 patient subgroups based on the combination of EBV DNA and miR‐BART7‐3p. Color coding is explained at the bottom of the panel. E, DMFS of patient groups at low or high risk of poor DMFS based on the combination of EBV DNA and miR‐BART7‐3p. F, OS of patient groups at low or high risk of poor OS based on the combination of EBV DNA and miR‐BART7‐3p